(NAPSA)-A new clinical trial-AIM-HIGH, sponsored by the National Heart, Lung, and Blood Institute-provides patients with FDA-approved therapies to manage both good and bad cholesterol levels. For more information or to join the trial, visit www.aimhigh-heart.com or call (888) 315-2948.
* * *
Alzheimer's disease is a progressive, degenerative disorder that attacks the brain's nerve cells, resulting in memory loss, thinking and language skills impairment and behavioral changes. You can learn more from the Alzheimer's Association at www.alz.org, the Alzheimer's Foundation of America at www.alzfdn.org and at www.alzheimersonline.com.
* * *
To better inform people with multiple sclerosis about their technology options, the MS Technology Collaborative, formed by Bayer HealthCare Pharmaceuticals, Microsoft and the National Multiple Sclerosis Society, launched a personalized, interactive program called Snapshot on www.MyMSMyWay.com.